跳到正文
原文
Nature 综合主刊· Miryam Naddaf·· 2026-10-05AI 评分61

2026年诺贝尔生理学或医学奖授予光遗传学技术

Medicine Nobel awarded for brain ‘switch’ that controls neurons with light

AI 导读

2026年诺贝尔生理学或医学奖于10月5日授予Karl Deisseroth、Peter Hegemann和Georg Nagel,以表彰光遗传学技术。该技术利用光脉冲控制大脑神经元,帮助科学家高精度探索大脑机制及抑郁症、帕金森病等疾病。

正文
Triptych featuring the 2026 Nobel prize winners in medicine from left to right Karl Deisseroth, Peter Hegemann and Georg Nagel.

Left to right: Karl Deisseroth, Peter Hegemann and Georg Nagel were awarded the 2026 medicine Nobel on 5 October.Credit: L-R Stanford Medicine, Humbold-Universität zu Berlin/Philipp Plum, Robert Emmerich/Universität Würzburg

After being on many scientists’ shortlists for years, optogenetics — a technology that allows researchers to control the brain’s neurons with pulses of light — has been recognized by the 2026 Nobel Prize in Physiology or Medicine. The technique has transformed how neuroscientists study the brain, offering them a way to test cause and effect.

‘What took them so long?’ This year’s medicine Nobel winner is overdue

The winners are Karl Deisseroth at Stanford University in California, Peter Hegemann at the Humboldt University of Berlin and Georg Nagel at the University of Würzburg in Germany. They share the prize of 12 million Swedish kronor (US$1.2 million) equally.

Deisseroth said that, as a night owl, he had been working late before he received the call from the Nobel committee. “It was a complete surprise,” he told a press conference held by Stanford University today. “I was lying down, just starting to drift off to sleep, and my phone rang at my bedside,” he said. “There were about 30 seconds where I had trouble forming words … but [it’s] very exciting and overwhelming, and just delightful.”

A switch neuroscientists dreamt of

Neuroscientists’ aim is to unpick the brain’s many roles: how it governs feelings, behaviours and bodily functions. To understand how the brain works and how its cells mediate different behaviours, scientists require an approach that can perturb the system with high precision.

“Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of,” said Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, in the press release announcing the prize.

Working together in the early 2000s, Hegemann and Nagel discovered a light-sensitive protein called channelrhodopsin1,2 in the alga Chlamydomonas reinhardtii, which is able to swim towards a light source. In response to blue light, the protein opens to allow charged molecules to flood into cells, creating a tiny electrical charge.

Can you name the women who have won a science Nobel prize?

In later work, Deisseroth and his colleagues inserted3 the gene encoding channelrhodopsin into neurons of rodents, and found that it caused the cells to fire and communicate with other neurons. The technology — a light-controlled ‘switch’ that allowed neuroscientists to alter specific cell types in the neural circuits of living brains using genetics — soon came to be known as optogenetics. It revolutionized neuroscience.

“We use light to turn on or off individual cells, or even types of cell or connections from one part of the brain to another. We can turn those on and off with millisecond precision in real time during behaviour, during cognition, and that allows us to see what actually matters for brain function and to start to map function and dysfunction precisely,” said Deisseroth. “It’s a real confluence of engineering and medicine.”

Illuminating the brain

The prizewinners’ work “fundamentally changed how we conduct neuroscience” and has “influenced fields far beyond it in biology, and opened new therapeutic possibilities,” says neuroscientist Rui Costa, who is president and chief executive of the Allen Institute in Seattle, Washington. “I first met Karl 23 years ago, and he was already thinking deeply about how to control the activity of specific neurons to understand and alter behaviour. Karl’s commitment not only to discovery, but also to sharing tools and reagents at scale, was equally transformative,” says Costa.

How to win a Nobel prize: what kind of scientist scoops medals?

The discovery and application of channelrhodopsin have led to a diverse ‘optogenetic toolkit’ that allows scientists in different fields to harness cellular activity with light.

Optogenetics has had a great impact on basic science, says Alexander Gottschalk, a neuroscientist at Goethe University Frankfurt in Germany. “It’s such an easy way, a very precise way, to define which cells should become responsive,” says Gottschalk. “Many people in the field have expected [this] for several rounds of Nobels already, but it took until now.”

Gottschalk has worked with all three winners, but knows Nagel the best. “He’s a humble person. He’s a modest person,” says Gottschalk. “I’m really happy that he received this prize today. It’s really well deserved.”

Into the clinic

Insights provided by optogenetic tools have helped researchers to better understand healthy brain function and conditions such as depression, schizophrenia, Parkinson’s and Alzheimer’s.

来源:Nature 综合主刊 · nature.com